Nutrients, neurodevelopment, and mood

Current Psychiatry Reports

Volumn 6, Issue 6, 2004, Pages 425-429

  Casper, Regina C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; PHENYLALANINE; PLACEBO; POLYUNSATURATED FATTY ACID; TRYPTOPHAN; TYROSINE;

AMINO ACID DEFICIENCY; BIPOLAR DISORDER; CALORIC INTAKE; CLINICAL TRIAL; CORRELATION ANALYSIS; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HUMAN; LOW BIRTH WEIGHT; MAJOR DEPRESSION; MATERNAL NUTRITION; MOOD DISORDER; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PREGNANCY; PREMATURITY; PRENATAL GROWTH; PREVALENCE; PROTEIN INTAKE; PSYCHOPATHY; PUERPERAL DEPRESSION; REVIEW; RISK ASSESSMENT; SCHIZOIDISM; SCHIZOPHRENIA; SCORING SYSTEM; SEROTONINERGIC SYSTEM; ADULT; AFFECT; BRAIN; DIET; EPIDEMIOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; NEWBORN; NUTRITIONAL STATUS; PRENATAL DEVELOPMENT; RISK FACTOR;

ADULT; AFFECT; BRAIN; DEPRESSIVE DISORDER; DIET; EPIDEMIOLOGIC STUDIES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MOOD DISORDERS; NUTRITIONAL STATUS; PREGNANCY; PRENATAL NUTRITION PHYSIOLOGY; RISK FACTORS;

EID: 16644402482     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-004-0006-z     Document Type: Review

References (63)

1. Tsuang M: Schizophrenia: genes and environment. Biol Psychiatry 2000, 47:210-220.
2. Uhl G, Grow R: The burden of complex genetics in brain disorders. Arch Gen Psychiatry 2004, 61:223-229.
3. Lesch K: Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 2004, 29:174-184.
4. Simopoulos A: Omega-3 fatty acids in health, disease, growth and development. Am J Clin Nutr 1991, 54:438-463.
5. Simopoulos A, Pavlou K: Nutrition and Fitness: Diet, Genes, Physical Activity and Health. Basel: Karger; 2001.
6. Liu W, Breen G, Zhang J, et al.: Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition. Schizophr Res 2003, 62:225-230.
7. Barcelo-Coblijn G, Kitajka K, Puskas L, et al.: Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochem Biophys Acta 2003, 1632:72-79.
8. Barker DJ: Intrauterine programming of coronary heart disease and stroke. Acta Paediatr Suppl 1997, 423:178-183.
9. Osmond C, Barker D: Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect 2000, 108(suppl 3):545-553.
10. Susser E, Neugebauer R, Hoek H, et al.: Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 1996, 53:25-31.
11. Susser E, Hoek H, Brown A: Neurodevelopmental disorders after prenatal famine. Am J Epidemiol 1998, 147:213-216.
12. Hoek H, Susser E, Buck K, et al.: Schizoid personality disorder after prenatal exposure to famine. Am J Psychiatry 1996, 153:1637-1639.
13. Hoek H, Brown A, Susser E: The Dutch famine and schizophrenia spectrum disorders. Soc Psychiatry Psychiatr Epidemiol 1998, 33:373-379.
14. Neugebauer R, Hoek H, Susser B: Prenatal exposure to wartime famine and development of antisocial personality disorder in early adulthood. JAMA 1999, 282:455-462.
15. Brown AS, Susser ES, Gorman JM, et al.: Increased risk of affective disorders in males after second trimester prenatal exposure to the Dutch Hunger Winter of 1944-45. Br J Psychiatry 1995, 166:601-606.
16. Patton G, Coffey C, Carlin J, et al.: Prematurity at birth and adolescent depressive disorder. Br J Psychiatry 2004, 184:446-447.
17. Barker D, Osmond C, Rodin I, et al.: Low weight gain in infancy and suicide in adult life. BMJ 1995, 311:1203.
18. Bourre J, Dumont O, Piciotti M, et al.: Dietary alpha-linolenic acid deficiency in adult rats for 7 months does not alter brain docosahexaenoic acid content, in contrast to liver, heart and testes. Biochim Biophys Acta 1992, 1124:119-122.
19. Connor W, Neuringer M, Lin D: Dietary effects on brain fatty acid composition: the reversibility of n-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys. J Lipid Res 1990, 31:237-247.
20. Reisbick S, Neuringer M, Hasnain R, Connor W: Home cage behavior of rhesus monkeys with long term deficiency of omega-3 fatty acids. Physiol Behav 1994, 55:231-239.
21. Olsen S, Sorensen J, Secher N, et al.: Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992, 339:1003-1007.
22. Olsen S, Secher N: Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study. BMJ 2002, 324:447.
23. Cheruku S, Montgomery-Downs H, et al.: Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002, 76:608-613.
24. Helland I, Smith L, Saarem K, et al.: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-44.
25. Auestad N, Scott DT, Janowsky I, et al.: Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 2003, 112:e177-83.
26. Ghys A, Bakker E, Hornstra G, van den Hout M: Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev 2002, 69:83-90.
27. Bakker E, Ghys A, Kester A, et al.: Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr 2003, 57:89-95.
28. Young SS, Smith SE, Pihl RO, Ervin FR: Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 1985, 87:173-177.
29. Carpenter L, Anderson G, Pelton G, et al.: Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 1998, 19:26-35.
30. Moreno F, Gelenberg A, Heninger G, et al.: Tryptophan depletion and depressive vulnerability. Biol Psychiatry 1999, 46:498-505.
31. Klaassen T, Riedel WJ, van Someren A, et al.: Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 1999, 46:489-497.
32. Knott V, Howson A, Perugini M, et al.: The effect of acute tryptophan depletion and fenfluranine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 1999, 46:229-238.
33. Bhatti T, Gillin J, Seifritz E, et al.: Effects of a tryptophan-free amino acid drink challenge on normal human sleep electro-encephalogram and mood. Biol Psychiatry 1998, 43:52-59.
34. Smith K, Morris J, Friston K, et al.: Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion. Br J Psychiatry 1999, 174:525-529.
35. Klaassen T, Riedel W, Deutz N, et al.: Specificity of the tryptophan depletion method. Psychopharmacology 1999, 141:279-286.
36. Aberg-Wistedt A, Hasselmark L, Stain-Malmgren R, et al.: A. Serotonergic 'vulnerability' in affective disorder: A study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders. Acta Psychiatr Scand 1998, 97:374-380.
37. Price L, Malison R, McDougle C, et al.: The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion. Biol Psychiatry 1998, 43:339-447.
38. Ravindran A, Griffiths J, Merali Z, et al.: Influence of acute tryptophan depletion on mood and immune measures in healthy males. Psychoneuroendocrinology 1999, 24:99-113.
39. Moorman J, Jackson A, Grahame-Smith D, Leslie R: Induction of c-fos in rat forebrain by pharmacological manipulation of 5-hydroxytryptamine levels. Neuroscience 1995, 68:1089-1096.
40. Leyton M, Young S, Pihl R, et al.: Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology 2000, 22:52-63.
41. Gibson E, Checkley S, Papadopoulos A, et al.: Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med 1999, 61:214-224.
42. Verger P, Lagarde D, Batejat D, Maitre J: Influence of the composition of a meal taken after physical exercise on mood, vigilance, performance. Physiol Behavi 1998, 64:317-322.
43. Markus C, Panhuysen G, Tuiten A, et al.: Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 1998, 31:49-65.
44. Maes M, Bosmans E, Meltzer H: Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995, 245:172-178.
45. Edwards M, Peet M, Shay J, Horrobin D: Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998, 48:149-155.
46. Hestad K, Tonseth S, Stoen C, et al.: Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003, 19:183-188.
47. Maes M, Smith R, Christophe A, et al.: Fatty acid composition in major depression: decreased 3 fractions in cholesteryl esters and increased C20:46/C20:53 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996, 38:1-71.
48. Hibbeln JR, Salem Jr N: Omega-3 Fatty Acids and Psychiatric Disorders. Totowa, NJ: Humana Press; 2001.
49. Nemets B, Stahl Z, Belmaker R: Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 2002, 159:477-479.
50. Peet M, Horrobin D: A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 2002, 59:913-919.
51. Marangell L, Martinez J, Zboyan H, et al.: A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003, 160:996-998.
52. Su K, Huang S, Chiu C, Shen W: Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003, 13:267-271.
53. Tiemeier H, van Tuijl HR, Hofman A, et al.: Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003, 78:40-46.
54. Hakkarainen R, Partonen T, Haukka J, et al.: Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 2004, 161:567-569.
55. Hibbeln J: Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-sectional, ecological analysis. J Affect Disord 2002, 69:15-29.
56. De Vriese S, Christophe A, Maes M: Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 2003, 73:3181-3187.
57. Llorente A, Jensen C, Voigt R, et al.: Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 2003, 188:1348-1353.
58. Marangell L, Martinez J, Zboyan H, et al.: Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. Depress Anxiety 2004, 19:20-23.
59. Champoux M, Hibbeln J, Shannon C, et al.: Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. Pediatr Res 2002, 51:273-281.
60. Chiu C, Huang S, Su K, et al.: Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 2003, 13:99-103.
61. Noaghiul S, Hibbeln JR: Cross-national comparisons of seafood consumption and rates of bipolar disorder. Am J Psychiatry 2003, 160:2222-2227.
62. Stoll A, Severus E, Freeman M, Rueter S: Omega 3 fatty acids in bipolar disorder. Arch Gen Psychiatry 1999, 56:407-412.
63. Keck P, McElroy S, Freeman M: Randomized controlled trial of eicosapentaenoic acid in bipolar depression and rapid cycling bipolar disorder. Bipolar Disord 2003, 5(suppl 1):58.